Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

F5 Networks, Inc. (FFIV): Time to Buy This Out-of-Fashion Tech Stock?

One of the hardest things to do in investing is to buy a stock that you know is out of fashion. With application delivery controller (ADC) specialist F5 Networks, Inc. (NASDAQ:FFIV) you have a classic case of a technology company that is attractively valued, but seeing slowing growth.

Typically, the market doesn’t reward such companies, and you can find yourself waiting a long time for the market to come around to your view. On the other hand, if F5 Networks, Inc. (NASDAQ:FFIV) can get back to growth the upside potential is significant.

F5 shifts

The recent third-quarter results were a return to form for F5 Networks, Inc. (NASDAQ:FFIV):

Revenues of $370 million vs. internal guidance of $355 million to $365 million

Non-GAAP EPS of $1.12 vs. internal guidance of $1.06 to $1.09

Fourth quarter (Q4) revenue guidance of $378 million to $388 million

Q4 Non-GAAP EPS guidance of $1.17 to $1.20

The stock appreciated sharply on the back of the revenue and earnings beat, but you need to look at the numbers in the context of long-term trends.

Source: F5 Networks accounts.

Growth is clearly slowing at F5 Networks, Inc. (NASDAQ:FFIV), and the guidance for Q4 isn’t particularly positive, either. With that said, Q3 was a significant improvement over F5’s nightmare in Q2. Essentially, its telco service provider revenues made a bit of a comeback.

Source: F5 Networks presentations.

F5 wasn’t the only company to report some weakness with spending from telco service providers in the spring. Other IT companies such as Fortinet reported a similar story. The good news is that some of the deals that slipped over from Q2 were closed in Q3. In addition, its U.S. enterprise revenues were surprisingly strong, particularly in an earnings season where tech bellwethers Oracle Corporation (NYSE:ORCL) and International Business Machines Corp. (NYSE:IBM) gave disappointing results.

Growth prospects?

The real question for investors: Can F5 Networks, Inc. (NASDAQ:FFIV) get out of its low-single-digit revenue-growth funk?

To do so, it must get product sales positive again. Representing 53% of total revenues, these sales declined 5% on the quarter, and are down 3.7% over the first three quarters. Indeed, on the conference call, F5’s management declared that generating product revenue growth would be its “No. 1 priority.” In the long term, its service revenues growth depends on getting more customers to install its products.

Moreover, there are other concerns with F5 Networks, Inc. (NASDAQ:FFIV):

The company has a dominant market share (over 50% according to most industry sources), so it will find it hard to grow by gaining market share from here.

Citrix Systems, Inc. (NASDAQ:CTXS) is growing its application delivery product NetScaler. Cisco Systems, Inc. (NASDAQ:CSCO) (which has discontinued investing in its ADC product) is recommending that its existing ADC customers integrate Netscaler.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.